RPS17P14

Across TCGA pan-cancer cohorts, RPS17P14 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS17P14’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPS17P14 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS17P14 is over-expressed in tumor, although a few such as THCA and ESCA show the opposite, repressed pattern.

THCA and ESCA are the cancer types where RPS17P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS17P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.060	<.001	5	view →
ESCA	All	All	−0.080	.027	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPS17P14–THCA

Open the THCA breakdown →